In this webcast, experts will discuss the history of DAPT duration for patients undergoing PCI with DES, review the contemporary data supporting shorter term DAPT duration for patients with HBR, translate the data into clinical practice and identify what gaps still exist, including what is the best monotherapy agent once DAPT has been terminated.

This webcast will discuss identification of patients, the importance of the multidisciplinary heart team, the role of the internist and clinical cardiologist in evaluation, asymptomatic patients, complications, procedural flow and patient follow-up.